MP David Davis calls for Vitamin D therapy to be rolled out ‘immediately’ …

Read Time: 2 minutes

MP David Davis calls for Vitamin D therapy to be rolled out ‘immediately’ after study finds it can ‘reduce Covid deaths by up to 60%’ – despite scientists saying further research is needed 

Vitamin D reduces Covid-19 deaths by 60 per cent, a study has found, as MP David Davis today called for the therapy to be rolled out in hospitals immediately to ‘save many thousands of lives.’

The study evaluated the effectiveness of calcifediol – a Vitamin D3 – on more than 550 people admitted to the Covid-19 wards of the Hospital del Mar in Barcelona, Spain. 

Subjects were randomly assigned as either recipients of the calcifediol treatment or as controls on admission, before receiving five doses of the vitamin in increasing intervals of two, four, eight and 15 days. 

The research, published by the Social Science Research Network, found Covid-19 patients given doses of Vitamin D were 80 per cent less likely to require ICU treatment. 

Those from the University of Barcelona also concluded that ‘adjusted results showed a reduced mortality of more than 60 per cent’ for those who were given the calcifediol treatment. 

Former Brexit Secretary David Davis today hailed the findings as ‘a very important study’, adding: ‘The findings of this large and well conducted study should result in this therapy being administered to every Covid patient in every hospital in the temperate latitudes.’

He said: ‘Furthermore, since the study demonstrates that the clear relationship between vitamin D and Covid mortality is causal, the UK government should increase the dose and availability of free vitamin D to all the vulnerable groups.

These approaches will save many thousands of lives. They are overdue and should be started immediately.’

The research, which is preliminary and not yet peer-reviewed, found 36 of the 551 patients treated with calcifediol died from Covid-19 compared to 57 patients out of 379 in the control group.   

Elsewhere, researchers found only five per cent of the calcifediol group were admitted to the ICU.   

The study said: ‘In this open randomised study conducted during the first European outbreak of the deadly Covid-19 pandemic, we have observed that, in hospitalised Covid-19 patients, treatment with calcifediol reduced the requirement for critical care by more than 80 per cent.